1. Home
  2. IPSC vs ESGL Comparison

IPSC vs ESGL Comparison

Compare IPSC & ESGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • ESGL
  • Stock Information
  • Founded
  • IPSC 2019
  • ESGL 1999
  • Country
  • IPSC United States
  • ESGL Singapore
  • Employees
  • IPSC N/A
  • ESGL N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • ESGL
  • Sector
  • IPSC Health Care
  • ESGL
  • Exchange
  • IPSC Nasdaq
  • ESGL Nasdaq
  • Market Cap
  • IPSC 58.1M
  • ESGL 64.6M
  • IPO Year
  • IPSC 2021
  • ESGL N/A
  • Fundamental
  • Price
  • IPSC $0.48
  • ESGL $2.02
  • Analyst Decision
  • IPSC Strong Buy
  • ESGL
  • Analyst Count
  • IPSC 5
  • ESGL 0
  • Target Price
  • IPSC $4.67
  • ESGL N/A
  • AVG Volume (30 Days)
  • IPSC 480.0K
  • ESGL 79.6K
  • Earning Date
  • IPSC 03-19-2025
  • ESGL 04-08-2025
  • Dividend Yield
  • IPSC N/A
  • ESGL N/A
  • EPS Growth
  • IPSC N/A
  • ESGL N/A
  • EPS
  • IPSC N/A
  • ESGL N/A
  • Revenue
  • IPSC $6,589,000.00
  • ESGL $6,264,048.00
  • Revenue This Year
  • IPSC N/A
  • ESGL N/A
  • Revenue Next Year
  • IPSC N/A
  • ESGL N/A
  • P/E Ratio
  • IPSC N/A
  • ESGL N/A
  • Revenue Growth
  • IPSC 194.81
  • ESGL 12.87
  • 52 Week Low
  • IPSC $0.47
  • ESGL $0.42
  • 52 Week High
  • IPSC $4.43
  • ESGL $3.00
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 26.49
  • ESGL 63.33
  • Support Level
  • IPSC $0.54
  • ESGL $1.86
  • Resistance Level
  • IPSC $0.59
  • ESGL $2.05
  • Average True Range (ATR)
  • IPSC 0.05
  • ESGL 0.16
  • MACD
  • IPSC -0.00
  • ESGL -0.01
  • Stochastic Oscillator
  • IPSC 3.08
  • ESGL 86.86

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

About ESGL ESGL Holdings Limited

ESGL Holdings Ltd Formerly Environmental Solutions Group Holdings Ltd is a waste management, treatment and recycling company involved in the collection and recycling of hazardous and non-hazardous industrial waste from customers such as pharmaceutical, semiconductor, petrochemical and electroplating companies.

Share on Social Networks: